NM_001384900.1:c.1272C>A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001384900.1(SEMA3D):​c.1272C>A​(p.His424Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00501 in 1,612,420 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0042 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0051 ( 24 hom. )

Consequence

SEMA3D
NM_001384900.1 missense

Scores

7
5
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:3

Conservation

PhyloP100: 1.65

Publications

15 publications found
Variant links:
Genes affected
SEMA3D (HGNC:10726): (semaphorin 3D) This gene encodes a member of the semaphorin III family of secreted signaling proteins that are involved in axon guidance during neuronal development. The encoded protein contains an N-terminal Sema domain, an immunoglobulin like domain and a C-terminal basic domain. The protein encoded by this gene binds neuropilin and plays an important role in cardiovascular development. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10156855).
BP6
Variant 7-85022533-G-T is Benign according to our data. Variant chr7-85022533-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 523626.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SEMA3DNM_001384900.1 linkc.1272C>A p.His424Gln missense_variant Exon 13 of 19 ENST00000284136.11 NP_001371829.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SEMA3DENST00000284136.11 linkc.1272C>A p.His424Gln missense_variant Exon 13 of 19 5 NM_001384900.1 ENSP00000284136.6 O95025
SEMA3DENST00000484038.1 linkn.398C>A non_coding_transcript_exon_variant Exon 4 of 10 1

Frequencies

GnomAD3 genomes
AF:
0.00421
AC:
639
AN:
151786
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000918
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00401
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00283
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00642
Gnomad OTH
AF:
0.00720
GnomAD2 exomes
AF:
0.00400
AC:
1004
AN:
250794
AF XY:
0.00413
show subpopulations
Gnomad AFR exome
AF:
0.000801
Gnomad AMR exome
AF:
0.00255
Gnomad ASJ exome
AF:
0.0131
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00254
Gnomad NFE exome
AF:
0.00592
Gnomad OTH exome
AF:
0.00573
GnomAD4 exome
AF:
0.00510
AC:
7444
AN:
1460516
Hom.:
24
Cov.:
31
AF XY:
0.00495
AC XY:
3595
AN XY:
726608
show subpopulations
African (AFR)
AF:
0.00111
AC:
37
AN:
33390
American (AMR)
AF:
0.00289
AC:
129
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.0139
AC:
362
AN:
26070
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.000302
AC:
26
AN:
86224
European-Finnish (FIN)
AF:
0.00249
AC:
133
AN:
53416
Middle Eastern (MID)
AF:
0.00782
AC:
45
AN:
5758
European-Non Finnish (NFE)
AF:
0.00569
AC:
6327
AN:
1111008
Other (OTH)
AF:
0.00638
AC:
385
AN:
60310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
369
739
1108
1478
1847
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00421
AC:
639
AN:
151904
Hom.:
3
Cov.:
32
AF XY:
0.00381
AC XY:
283
AN XY:
74238
show subpopulations
African (AFR)
AF:
0.000915
AC:
38
AN:
41508
American (AMR)
AF:
0.00401
AC:
61
AN:
15216
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
54
AN:
3460
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5122
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00283
AC:
30
AN:
10606
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.00642
AC:
436
AN:
67860
Other (OTH)
AF:
0.00713
AC:
15
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
34
67
101
134
168
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00544
Hom.:
3
Bravo
AF:
0.00414
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00675
AC:
26
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00523
AC:
45
ExAC
AF:
0.00371
AC:
451
Asia WGS
AF:
0.000866
AC:
4
AN:
3478
EpiCase
AF:
0.00764
EpiControl
AF:
0.00670

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Aganglionic megacolon Pathogenic:1Uncertain:1
-
Human Genomics Unit, Institute for molecular medicine Finland (FIMM)
Significance:Likely pathogenic
Review Status:flagged submission
Collection Method:research

- -

Nov 20, 2017
Center of Genomic medicine, Geneva, University Hospital of Geneva
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was identified in a patient with Hirschsprung disease and a positive familial history. The patient harbours also a variant in the RET gene, which is a risk factor for this disease. -

not provided Benign:2
Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SEMA3D: BS1, BS2 -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SEMA3D-related disorder Benign:1
May 23, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Benign
-0.076
T
BayesDel_noAF
Uncertain
0.12
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.21
T
Eigen
Uncertain
0.32
Eigen_PC
Benign
0.16
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.81
T
M_CAP
Pathogenic
0.33
D
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-0.63
T
MutationAssessor
Pathogenic
3.8
H
PhyloP100
1.6
PrimateAI
Uncertain
0.54
T
PROVEAN
Pathogenic
-7.8
D
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.99
MutPred
0.90
Loss of catalytic residue at S425 (P = 0.1052);
MVP
0.60
MPC
0.65
ClinPred
0.11
T
GERP RS
0.088
Varity_R
0.93
gMVP
0.85
Mutation Taster
=30/70
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141893504; hg19: chr7-84651849; API